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Abstract 
 
Aim: to determine the role of targeted four node sampling (FNS) in axillary mapping in operable breast cancer. 
Methods: The present analytical hospital based study was conducted among histopathologically and cytologically 
confirmed patients of operable breast cancer admitted to inpatient department of General Surgery, Sri Krishna 
Medical College and Hospital, Muzaffarpur, India July 2019 to February 2020. A total of 30 patients, node negative 
operable cases of carcinoma breast after 3 cycles of neoadjuvant chemotherapy, were enrolled. Lymph node 
mapping was done by injecting 3 - 5 ml of methylene blue dye, just before surgery. Results: The sensitivity, 
specificity, positive predictive value and negative predictive value of 83.12%, 90.27%, 72.31% and 94.25% 
respectively for four node sampling of axilla, among operable breast cancer patients having node negative 
axilla.Conclusions: Targeted four node sampling using methylene blue dye can be considered as an alternative 
method for sentinel lymph node. Further study should be conducted to establish it as a reliable method for axillary 
lymph node staging. 
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Introduction 
 
 
 
Breast cancer is the most frequent cancer among 
women in the world with an estimated 1.67 million 
new cancer cases diagnosed in 2012 which constituted 
about 25% of all cancers. It ranks second overall 
among all cancers in the world. Women from less 
developed regions have slightly more number of cases 
compared to more developed regions[1].  
______________________ 
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Earlier cervical cancer was most common cancer in 
Indian woman but now the incidence of breast cancer 
has surpassed cervical cancer and is leading cause of 
cancer death, although cervical cancer still remains 
most common in rural India[2]. Since axillary lymph 
node involvement is the most important prognostic 
marker of outcome, and important prognostic factor for 
breast cancer till now, axillary lymph node 
addressal/dissection has been considered an essential 
component of breast cancer management[3-5]SNB is 
now widely used for the staging of clinically node-
negative patients with breast cancer. It is highly 
accurate in predicting the status of both the axillary and 
the extra-axillary lymph nodes[6] The technique of 
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four node axillary sampling was pioneered in the 
Edinburgh breast unit and relies on the theory that the 
axillary nodes most likely to be involved are those that 
are palpable intraoperatively[7,8] However, four node 
axillary sampling still seems to be an attractive method 
for minimally invasive axillary surgery because of no 
additional prerequisites, its possible usefulness in areas 
with limited sources. Hence the present study was 
conducted with the aim to determine the role of 
targeted four node sampling (FNS) in axillary mapping 
in operable breast cancer[9-11]. 
Materials and methods  
The present analytical hospital based study was 
conducted among histopathologically and cytologically 
confirmed patients of operable breast cancer admitted 
to inpatient department of General Surgery, Sri Krishna 
Medical College and Hospital, muzaffarpur,Bihar,India 
from July 2019 to feb 2020.The study protocol was 
reviewed by the Concerned Ethical Committee and was 
granted ethical clearance. After explaining the purpose 
and details of the study, a written informed consent 
was obtained 
Sample selection 
The sample size was calculated using a prior type of 
power analysis by G* Power Software Version 3.0.1.0 
(Franz Faul, Universitat Kiel, Germany). The minimum 
sample size was calculated, following these input 
conditions: estimated prevalence of 40%, power of 
0.80 and P ≤ 0.05 and sample size arrived were 30.  
Surgical technique  
Operative technique of targeted four node sampling 
which was followed was, after draping the patient, 3-5 
mL of methylene blue dye was injected intradermally 
in the peri areolar region followed by breast massage 
for 5 min. After raising the superior flap, axilla was 
dissected and blue nodes at level-I was picked up from 
within the anatomical boundaries of the defined 
quadrangle bounded by upper intercostobrachial nerve 
superiorly, chest wall medially, thoracodorsal pedicle 
laterally, lateral border of pectoralis major anteriorly, 
and lateral border of latissimus dorsi laterally. Blue 
nodes from the above-mentioned quadrangle were 
sampled and sent for histopathological examination. 
The final histopathology reports of rest of the axilla 
were compared with the sampled blue nodes to assess 
the sensitivity/specificity and positive predictive and 
negative predictive value of the technique.  
Statistical analysis  
The recorded data was compiled and entered in a 
spreadsheet computer program (Microsoft Excel 2010) 
and then exported to data editor page of SPSS version 
19 (SPSS Inc., Chicago, Illinois, USA). Descriptive 
statistics included computation of percentages and 
means. The statistical test applied for the analysis was 
independent sample t-test. The confidence interval and 
p-value were set at 95% and ≤ 0.05 respectively. 
 
Results  
Table 1: demographic and clinical profile 
Age (years) 56.16±2.89 
Tumor type   
Not special type  21 
Lobular  6 
Tubular  3 
Mean Number of Node  1.87±0.39 
Mean Number of all axillary nodes 12.31±2.21 
 
Table 2: diagnostic accuracy of four node sampling 
FNS 
Sensitivity Specificity PPV NPV 
With total number of patients  
82.45 80.13 53.62 93.41 
With operable node negative patients  
83.12 90.27 72.31 94.25 
 
 
Discussion 
  
The surgical management of axillary lymph nodes in 
early breast cancer remains controversial, although 
several maneuvers have been developed such as 
axillary clearance, pectral node biopsy, four node 
sampling, triple node biopsy, and sentinel lymph node 
biopsy[5].In the present investigation sensitivity of four 
node sampling method to diagnose the metastasis is 
found to be 82%, while specificity was observed to be 
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80%, with positive predictive value of 50% and 
negative predictive value of 93%. Chintamani et al, in 
their study found sensitivity of four node sampling as 
89.5%, specificity of 100%, diagnostic accuracy of 
93.3% and negative predictive value of 84.6%[6] 
RD Macmillan et al., in their study observed that 30% 
cases were positive for four node sampling, with 
sensitivity of 96% and FNR of 17%. They found PPV 
of 86%[7]Comparative Japanese study of 206 patients 
of operable breast cancer undergoing sentinel lymph 
node biopsy and four node sampling 
procedure(Edinburgh technique) showed that the 
accuracy and sensitivity of 4NAS (98% and 96%) was 
comparable to that of sentinel lymph node biopsy (99% 
and 98%), respectively. The study concluded that four 
node sampling can be considered an alternate safe and 
easy procedure for axillary staging[7,8]“Nottingham 
Breast Unit”, studied 200 patients (T1-2/ N0) and 
directly compared sentinel lymph node biopsy using 
hot node technique (lympho-scintigraphy) with four 
node sampling (Edinburgh technique). Sentinel lymph 
node was identified in 191 patients (96%) and when 
compared with SLNB, four node sampling failed to 
identify metastasis in one patient (2%). On the 
contrary, sentinel lymph node biopsy failed to identify 
metastasis in eight (14%) patients in whom four node 
sampling detected axillary lymph node metastasis and 
hence under-staged the axilla. They concluded that 
sentinel lymph node biopsy performed using radio 
labeled colloid has no advantage over four node 
sampling. 
 
Conclusion  
 
In the present study we have observed a sensitivity, 
specificity, positive predictive value and negative 
predictive value of 82.45%, 80.13%, 53.62% and 
93.41% respectively for four node sampling of axilla 
amongst all the patients. Our study also observed a 
sensitivity, specificity, positive predictive value and 
negative predictive value of 83.12%, 90.27%, 72.31% 
and 94.25% respectively for four node sampling of 
axilla, among operable breast cancer patients having 
node negative axilla. 
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